Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

63 results
Display

Successful Treatment of Acinetobacter Baumannii Meningitis with Colistin

Choi PK, Kim KH, Kang HG

Acinetobacter baumannii is a source of opportunistic infection in hospital and can cause central nervous system infection mainly by neurosurgical operation. Community acquired infection by Acinetobacter baumannii is very rare....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii

Choi HK, Kim YK, Kim HY, Uh Y

PURPOSE: Colistin is used for the treatment of pneumonia associated with multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. However, the best route of administration and dosage is not known. We report...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Colistin, Hot Potato for the Therapy of Carbapenem-resistant Acinetobacter baumannii infections

Park SW

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Discordance in Colistin Susceptibility Test for Acinetobacter baumannii Showing Resistance: MicroScan versus Etest

Kang G, Kim HS, Kim HS, Song W, Kim JS

BACKGROUND: Acinetobacter baumannii causes various hospital-acquired infections, its multidrug resistance is rapidly increasing worldwide. Although colistin is used in treatments against multidrug-resistant A. baumannii, resistance to colistin has also been...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Synergistic Action of Gentamicin and Colistin on Pseudomonas Aeruginosa

Lee WR, Ihn JC, Lee SY, Kim ID, Chung JG

Gentamicin and colistin are drug of choice for the treatment of pseudomonas infection, however, the synergistic action of these drugs on the pseudomonas has not been documented clearly. The author...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Susceptibility of Clinical Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa to Colistin and Polymyxin B in Korea

Song W, Lee TJ, Park MJ, Kim HS, Kim JS, Woo HJ, Lee KM

  • KMID: 2285066
  • Infect Chemother.
  • 2006 Dec;38(6):362-366.
BACKGROUND: The emergence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa has become a major problem. The use of nontraditional agents such as colistin and polymyxin B have been tried. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
ISAba15 Inserted into Outer Membrane Protein Gene carO in Acinetobacter baumannii

Kim DH, Ko KS

We identified ISAba15 inserted into the carO gene in an Acinetobacter baumannii isolate. The insert disrupted the lpxD gene, resulting in colistin resistance in A. baumannii. Persistence in carbapenem resistance...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Colistin Resistance in Escherichia coli Isolates From Patients With Bloodstream Infection in Korea

Kim YA, Yong D, Jeong SH, Lee K

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of drug resistant bacteria: new bugs, old drugs, and new therapeutic approaches

Choi YH

Rapidly increasing antimicrobial resistance and lack of effective antibiotics are dilemma in the treatment of infectious diseases. Clinicians are now considering the use of old antibiotics such as colistin, fosfomycin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Comparative Efficacy of Colistin Monotherapy and Combination Therapy Based on in vitro Antimicrobial Synergy in Ventilator-associated Pneumonia Caused by Multi-drug Resistant Acinetobacter baumannii

Jang HJ, Kim MN, Lee K, Hong SB, Lim CM, Koh Y

  • KMID: 2319226
  • Tuberc Respir Dis.
  • 2009 Sep;67(3):212-220.
BACKGROUND: Ventilator-associated pneumonia caused by multi-drug resistant Acinetobacter baumannii has been increasing and growing as a threat in intensive care units. Limited therapeutic options have forced clinicians to choose colistin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Determination of Colistin Resistance by Simple Disk Diffusion Test Using Modified Mueller-Hinton Agar

Uwizeyimana JD, Kim D, Lee H, Byun JH, Yong D

BACKGROUND: Colistin has become a last-resort antibiotic for the management of multidrug-resistant gram-negative bacteria. The disk diffusion test is cheap and easy to perform but may be unreliable for colistin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment

Park YJ, Hong DJ, Yoon EJ, Kim D, Choi MH, Hong JS, Lee H, Yong D, Jeong SH

BACKGROUND: The increasing morbidity and mortality rates associated with Acinetobacter baumannii are due to the emergence of drug resistance and the limited treatment options. We compared characteristics of colistin-resistant Acinetobacter...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Outcomes of Using Colistin for Treating Multidrug Resistant Acinetobacter Species Bloodstream Infections

Lim SK, Lee SO, Choi SH, Choi JP, Kim SH, Jeong JY, Choi SH, Woo JH, Kim YS

Despite the identification of Acinetobacter baumannii isolates that demonstrate susceptibility to only colistin, this antimicrobial agent was not available in Korea until 2006. The present study examined the outcomes of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of clinical characteristics of patients with acute kidney injury after intravenous versus inhaled colistin therapy

Cho AY, Yoon HJ, Lee JC, Kwak JY, Lee KY, Sun IO

BACKGROUND: The aim of this study was to investigate the incidence and clinical characteristics of intravenous (IV) or inhaled (IH) colistin-associated acute kidney injury (AKI) using the Risk, Injury, Failure,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Aerosol Colistin Treatment of Pneumonia Caused by Multi-drug Resistant Acinetobacter baumannii

Choi HS, Hwang YH, Park MJ, Kang HM

BACKGROUND: Acinetobacter infections are difficult to treat as they often exhibit multiple resistance to the antibiotics that are currently available for the treatment of pneumonia. Colistin is active against gram-negative...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
In Vitro Activity of Antimicrobial Combination against Multidrug-resistant Strains of Acinetobacter baumannii

Lee MA, Moon HW

  • KMID: 2238959
  • Korean J Lab Med.
  • 2005 Oct;25(5):312-316.
BACKGROUND: Acinetobacter baumannii has been reported as a major cause of nosocomial infections with increasing frequency. Recently, the emergence of carbapenem-resistant strains has become a major problem in treatment. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
In vitro Comparison of Anti-Biofilm Effects against Carbapenem-Resistant Acinetobacter baumannii: Imipenem, Colistin, Tigecycline, Rifampicin and Combinations

Song JY, Cheong HJ, Noh JY, Kim WJ

BACKGROUND: Multi-drug resistant (MDR) Acinetobacter baumannii has emerged as one of the most important nosocomial pathogens. In addition to the diverse resistance mechanisms, some A. baumannii strains are known to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Successful Treatment Using Topical Colistin in Multidrug-resistant Pseudomonas aeruginosa Bacterial Ulcer

Seo MH, Na YH, Lee DH, Kim JH

PURPOSE: To report a successful case of corneal ulcer caused by multidrug-resistant Pseudomonas aeruginosa using topical colistin in an immobilized patient who was hospitalized for a long period. CASE SUMMARY: An...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Significance of Acute Kidney Injury in Patients with Colistin Treatment

Nam WJ, Shin JH, Han MJ, Park YS, Kim SH, Oh DJ, Yu SH

  • KMID: 2252637
  • Korean J Nephrol.
  • 2011 Sep;30(5):484-491.
PURPOSE: Colistin (colistimethate sodium) became available for clinical use in 1959 and was used until the early 1980s to treat infections caused by Gram-negative rods. It was abandoned during the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Trial of Aerosolized Colistin for the Treatment of Nosocomial Pneumonia due to Multidrug-resistant Acinetobacter baumannii

Kim C, Kim DG, Kang HR, Choi JH, Lee CY, Hwang YI, Shin TR, Park SM, Park YB, Lee JY, Jang SH, Kim CH, Mo EK, Lee MG, Hyun IG, Jung KS, Choi YJ, Lee JW

  • KMID: 2319015
  • Tuberc Respir Dis.
  • 2008 Feb;64(2):102-108.
BACKGROUND: Recently, multidrug-resistant (MDR) A. baumannii has been implicated for a significant proportion of nosocominal pneumonia in many intensive care units (ICUs), and its acquisition may increase mortality and the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr